101 related articles for article (PubMed ID: 32020064)
1. Lipidome-based rapid diagnosis with machine learning for detection of TGF-β signalling activated area in head and neck cancer.
Ishii H; Saitoh M; Sakamoto K; Sakamoto K; Saigusa D; Kasai H; Ashizawa K; Miyazawa K; Takeda S; Masuyama K; Yoshimura K
Br J Cancer; 2020 Mar; 122(7):995-1004. PubMed ID: 32020064
[TBL] [Abstract][Full Text] [Related]
2. Construction of mass spectra database and diagnosis algorithm for head and neck squamous cell carcinoma.
Ashizawa K; Yoshimura K; Johno H; Inoue T; Katoh R; Funayama S; Sakamoto K; Takeda S; Masuyama K; Matsuoka T; Ishii H
Oral Oncol; 2017 Dec; 75():111-119. PubMed ID: 29224807
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated TGF-beta1-induced Smad signalling occurs as a result of defects in multiple components of the TGF-beta signalling pathway in human head and neck carcinoma cell lines.
Pring M; Prime S; Parkinson EK; Paterson I
Int J Oncol; 2006 May; 28(5):1279-85. PubMed ID: 16596245
[TBL] [Abstract][Full Text] [Related]
4. Frequent alterations of Smad signaling in human head and neck squamous cell carcinomas: a tissue microarray analysis.
Xie W; Bharathy S; Kim D; Haffty BG; Rimm DL; Reiss M
Oncol Res; 2003; 14(2):61-73. PubMed ID: 14649540
[TBL] [Abstract][Full Text] [Related]
5. Disruption of transforming growth factor-beta signaling by five frequently methylated genes leads to head and neck squamous cell carcinoma pathogenesis.
Bennett KL; Romigh T; Eng C
Cancer Res; 2009 Dec; 69(24):9301-5. PubMed ID: 19934318
[TBL] [Abstract][Full Text] [Related]
6. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
[TBL] [Abstract][Full Text] [Related]
7. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
[TBL] [Abstract][Full Text] [Related]
8. Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.
Qiu W; Schönleben F; Li X; Su GH
Cancer Lett; 2007 Jan; 245(1-2):163-70. PubMed ID: 16478646
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation a TGF-β-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method.
Huang T; Huang W; Lu H; Zhang BY; Ma J; Zhao D; Wang YJ; Yu DH; He X
J Transl Med; 2018 Feb; 16(1):46. PubMed ID: 29490660
[TBL] [Abstract][Full Text] [Related]
10. CXCR7 promotes migration and invasion in head and neck squamous cell carcinoma by upregulating TGF-β1/Smad2/3 signaling.
Kim N; Ryu H; Kim S; Joo M; Jeon HJ; Lee MW; Song IC; Kim MN; Kim JM; Lee HJ
Sci Rep; 2019 Dec; 9(1):18100. PubMed ID: 31792315
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts.
Rosenthal E; McCrory A; Talbert M; Young G; Murphy-Ullrich J; Gladson C
Mol Carcinog; 2004 Jun; 40(2):116-21. PubMed ID: 15170816
[TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
[TBL] [Abstract][Full Text] [Related]
13. A new rapid diagnostic system with ambient mass spectrometry and machine learning for colorectal liver metastasis.
Kiritani S; Yoshimura K; Arita J; Kokudo T; Hakoda H; Tanimoto M; Ishizawa T; Akamatsu N; Kaneko J; Takeda S; Hasegawa K
BMC Cancer; 2021 Mar; 21(1):262. PubMed ID: 33691644
[TBL] [Abstract][Full Text] [Related]
14. Involvement of smad2 and Erk/Akt cascade in TGF-β1-induced apoptosis in human gingival epithelial cells.
Yoshimoto T; Fujita T; Kajiya M; Matsuda S; Ouhara K; Shiba H; Kurihara H
Cytokine; 2015 Sep; 75(1):165-73. PubMed ID: 25882870
[TBL] [Abstract][Full Text] [Related]
15. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
16. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia.
Lima JDCC; Simoes E; de Castro G; Morais MRPT; de Matos-Neto EM; Alves MJ; Pinto NI; Figueredo RG; Zorn TMT; Felipe-Silva AS; Tokeshi F; Otoch JP; Alcantara P; Cabral FJ; Ferro ES; Laviano A; Seelaender M
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1045-1059. PubMed ID: 31273954
[TBL] [Abstract][Full Text] [Related]
17. Screening key lncRNAs with diagnostic and prognostic value for head and neck squamous cell carcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
Hu Y; Guo G; Li J; Chen J; Tan P
Cancer Biomark; 2020; 27(2):195-206. PubMed ID: 31815689
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic DRAK1 overexpressed in head and neck cancers inhibits TGF-β1 tumor suppressor activity by binding to Smad3 to interrupt its complex formation with Smad4.
Park Y; Kim W; Lee JM; Park J; Cho JK; Pang K; Lee J; Kim D; Park SW; Yang KM; Kim SJ
Oncogene; 2015 Sep; 34(39):5037-45. PubMed ID: 25531329
[TBL] [Abstract][Full Text] [Related]
19. TGF beta signalling and its role in tumour pathogenesis.
Kaminska B; Wesolowska A; Danilkiewicz M
Acta Biochim Pol; 2005; 52(2):329-37. PubMed ID: 15990918
[TBL] [Abstract][Full Text] [Related]
20. Anti- or pro-proliferation—conditional options for TGF-α and cetuximab in head and neck squamous cell carcinoma.
Ekblad L; Welinder C; Kjellén E; Brun E; Wennerberg J
Oral Oncol; 2015 Jan; 51(1):46-52. PubMed ID: 25261297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
